Search Results

You are looking at 11 - 20 of 153 items for :

  • "genetic counseling" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

Extending Comprehensive Cancer Center Expertise in Clinical Cancer Genetics and Genomics to Diverse Communities: The Power of Partnership

Deborah J. MacDonald, Kathleen R. Blazer, and Jeffrey N. Weitzel

subsequent visit; the physician uses evaluation and management codes to bill for visits. At Good Samaritan Medical Center in Arizona, an APN with board certification in genetic counseling provides cancer risk counseling and administers the program with

Full access

Genetic/Familial High-Risk Assessment: Breast and Ovarian

Mary B. Daly, Jennifer E. Axilbund, Saundra Buys, Beth Crawford, Carolyn D. Farrell, Susan Friedman, Judy E. Garber, Salil Goorha, Stephen B. Gruber, Heather Hampel, Virginia Kaklamani, Wendy Kohlmann, Allison Kurian, Jennifer Litton, P. Kelly Marcom, Robert Nussbaum, Kenneth Offit, Tuya Pal, Boris Pasche, Robert Pilarski, Gwen Reiser, Kristen Mahoney Shannon, Jeffrey R. Smith, Elizabeth Swisher, and Jeffrey N. Weitzel

applying these guidelines to individual families. Furthermore, these guidelines were not developed as a substitute for professional genetic counseling. Rather, they are intended to help health care providers identify individuals who may benefit from cancer

Full access

High-Risk Prevention Programs: Identifying Services for High-Risk Patients

Presented by: Michael J. Hall

modified to shorten genetic counseling before testing. Which Patients Present for Risk Assessment? Previously, the typical patient population who presented for hereditary cancer risk assessment included high-risk patients with a strong personal or

Full access

Multigene Testing for Hereditary Cancer: When, Why, and How

Kenneth Offit

,” Dr. Offit stated at the outset of his talk. Currently, NCCN does not endorse routing multiplex testing outside of a research setting, and/or intensive genetic counseling regarding risks and benefits. The 2017 NCCN Clinical Practice Guidelines in

Full access

Gene Panel Testing for Inherited Cancer Risk

Michael J. Hall, Andrea D. Forman, Robert Pilarski, Georgia Wiesner, and Veda N. Giri

inherited cancer risk when first-line evaluation has been inconclusive All discussions must include the risks and benefits of gene panel testing in a genetic counseling setting, with informed consent reflecting the discussion. Choice of Laboratory

Full access

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024

Featured Updates to the NCCN Guidelines

Mary B. Daly, Tuya Pal, Kara N. Maxwell, Jane Churpek, Wendy Kohlmann, Zahraa AlHilli, Banu Arun, Saundra S. Buys, Heather Cheng, Susan M. Domchek, Susan Friedman, Veda Giri, Michael Goggins, Andrea Hagemann, Ashley Hendrix, Mollie L. Hutton, Beth Y. Karlan, Nawal Kassem, Seema Khan, Katia Khoury, Allison W. Kurian, Christine Laronga, Julie S. Mak, John Mansour, Kevin McDonnell, Carolyn S. Menendez, Sofia D. Merajver, Barbara S. Norquist, Kenneth Offit, Dominique Rash, Gwen Reiser, Leigha Senter-Jamieson, Kristen Mahoney Shannon, Kala Visvanathan, Jeanna Welborn, Myra J. Wick, Marie Wood, Matthew B. Yurgelun, Mary A. Dwyer, and Susan D. Darlow

intended to serve as a resource for health care providers to identify individuals who may benefit from cancer risk assessment and genetic counseling and testing; provide genetics health care professionals with an updated tool for the assessment of

Full access

Diagnosis and Management of Rectal Cancer in Patients Younger Than 50 Years: Rising Global Incidence and Unique Challenges

Daenielle Lang and Kristen K. Ciombor

counseling, financial guidance, reproductive health, genetic counseling, nutrition, psychosocial distress, spirituality, and physical and mental well-being. 41 There should be discussion of fertility preservation with these patients of childbearing age prior

Full access

Germline and Somatic Mutations in Prostate Cancer for the Clinician

Heather H. Cheng, Alexandra O. Sokolova, Edward M. Schaeffer, Eric J. Small, and Celestia S. Higano

actionability of widespread genetic testing in early, low-risk prostate cancer settings without other risk factors remain unclear, and short-term unintended consequences include clinical confusion and low-yield depletion of limited genetic counseling resources

Full access

A Young Woman With Bilateral Breast Cancer: Identifying a Genetic Cause and Implications for Management

Monique A. de Bruin, James M. Ford, and Allison W. Kurian

bilateral breast cancer at a young age, she met NCCN criteria for BRCA1/2 mutation testing. 1 She underwent appropriate genetic counseling and then BRCA1/2 mutation testing by full sequencing, which was negative. BRCAnalysis Comprehensive Rearrangement

Full access

Counterpoint: Implementing Population Genetic Screening for Lynch Syndrome Among Newly Diagnosed Colorectal Cancer Patients—Will the Ends Justify the Means?

Michael J. Hall

, and by whom consent would be obtained in a population screening program remain unanswered. 7 , 9 , 13 Low provider knowledge of MSI/IHC and scarce genetic counseling resources 14 would likely leave many patients poorly informed about the